BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18848798)

  • 1. Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia.
    Chiu SK; Chang FY
    Int J Infect Dis; 2009 May; 13(3):e85-7. PubMed ID: 18848798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Cueto Md; Gálvez J; Perea EJ; Pascual A
    Clin Microbiol Infect; 2008 Feb; 14(2):180-3. PubMed ID: 18005358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
    Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
    Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
    J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
    Wu UI; Chen WC; Yang CS; Wang JL; Hu FC; Chang SC; Chen YC
    Int J Infect Dis; 2012 Jan; 16(1):e47-52. PubMed ID: 22055248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies.
    Vigil KJ; Johnson JR; Johnston BD; Kontoyiannis DP; Mulanovich VE; Raad II; Dupont HL; Adachi JA
    Clin Infect Dis; 2010 Feb; 50(3):374-80. PubMed ID: 20038242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase].
    Hori J; Yamaguchi S; Osanai H; Kinebuchi T; Usami K; Takahashi N; Ishii Y
    Hinyokika Kiyo; 2007 Nov; 53(11):777-82. PubMed ID: 18051801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli pyomyositis in an immunocompromised host.
    Sharma U; Schwan WR; Agger WA
    WMJ; 2011 Aug; 110(4):182-4. PubMed ID: 22413629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diagnostic delay on the course of septic shock caused by extended-spectrum-beta- lactamase-producing Escherichia coli.
    Gashi M; Raka L; Ahmeti S; Gashi S; Dika A; Gashi G
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):846-7. PubMed ID: 19736487
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
    Memon JI; Rehmani RS; Ahmed MU; Elgendy AM; Nizami IY
    Saudi Med J; 2009 Jun; 30(6):803-8. PubMed ID: 19526164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli.
    Nakwan N; Nakwan N; Wannaro J; Dissaneevate P; Kritsaneepaiboon S; Chokephaibulkit K
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):148-51. PubMed ID: 21323177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
    Suankratay C; Jutivorakool K; Jirajariyavej S
    J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.
    Nicolle LE; Mulvey MR
    Scand J Infect Dis; 2007; 39(8):748-9. PubMed ID: 17654359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of multidrug-resistant Escherichia coli bacteremia with tigecycline in an acute myeloid leukemia child.
    Ozdemir H; Ciftçi E; Karbuz A; Oktay G; Aysev D; Yavuz G; Ince E
    Turk J Pediatr; 2012; 54(1):59-60. PubMed ID: 22397044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.